PPT-Edward Fox, MD, PhD Phase 2 Multicenter Study Results of
Ublituximab a Novel Glycoengineered AntiCD20 Monoclonal Antibody mAb in Patients with Relapsing Forms of Multiple Sclerosis RMS Novel Glycoengineered AntiCD20 mAb
Download Presentation
"Edward Fox, MD, PhD Phase 2 Multicenter Study Results of" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.